I-Mab First Half 2024 Earnings: US$0.19 loss per share (vs US$1.32 loss in 1H 2023)

Simply Wall St · 08/30 11:47

I-Mab (NASDAQ:IMAB) First Half 2024 Results

Key Financial Results

  • Net loss: US$15.7m (loss narrowed by 86% from 1H 2023).
  • US$0.19 loss per share (improved from US$1.32 loss in 1H 2023).
earnings-and-revenue-history
NasdaqGM:IMAB Earnings and Revenue History August 30th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

I-Mab Earnings Insights

Looking ahead, revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Biotechs industry in the US.

Performance of the American Biotechs industry.

The company's shares are down 6.7% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 3 warning signs for I-Mab you should know about.